Home › Bone Cancer › NCT06409013
Evaluation of Tumor Resection Guided by Intraoperative Indocyanine Green Dye Fluorescence Angiography in Patients With Sarcoma
RecruitingObservational study
Sarcoma Resection Guided by Intraoperative Indocyanine Green Dye Fluorescence Angiography
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * Patients with biopsy-proven bone or soft tissue sarcoma undergoing resection Exclusion Criteria: * Chronic kidney disease * Anaphylaxis to dyes
About the study
This study evaluates the effectiveness of intraoperative indocyanine green dye and fluoroscopic technology in confirming negative margins after tumor removal.
What is being tested
- Non-Interventional Study (other)
Sponsor: Mayo Clinic · Participants: 75 · Started: Mar 14, 2024
Contact the study team
- Clinical Trials Referral Office · Phone: 855-776-0015
- Laura Dohrmann · Phone: 507-266-5886
Official record on ClinicalTrials.gov — NCT06409013
Locations in the U.S.
| Minnesota | Mayo Clinic in Rochester, Rochester |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.